203293
InSolution™ Bisindolylmaleimide I
2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide, Gö 6850
Wenn Sie allgemeine Fragen haben, wenden Sie sich bitte an unseren Kundenservice:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Telefon: +49 6151 72-0
Fax: +49 6151 72 2000
15 Februar 2012
wird geladen
| Produktinformationen | |||
|---|---|---|---|
| Form | Liquid | ||
| Formulation | A 1 mg/ml solution of Bisindolylmaleimide I (Cat. No. 203290) in anhydrous DMSO. | ||
| Primary Target | PKC | ||
| Primary Target Ki | 10 nM | ||
| Secondary target | GSK-3 (IC50 = 360 nM), GSK-3β (IC50 = 170 nM), PKA (Ki = 2 mM) | ||
| Packaged under inert gas | Ja | ||
| Cell permeable | Ja | ||
| Reversible | Ja | ||
| ATP Competitive | Ja | ||
| Purity | ≥95% by HPLC | ||
| Chemische Formel | C25H24N4O2 | ||
| CAS-Nummer | 133052-90-1 | ||
| Lager- und Versandinformationen | |||
|---|---|---|---|
| Lagerkategorie | -20°C | ||
| Ship |
Blue Ice Only
Irritant |
||
| Sicherheitshinweise | |||
|---|---|---|---|
| S-Satz |
S: 26 |
||
| R-Satz |
R: 36/38 |
||
